Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
Clinical trial NCT07260162 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07260162
- Sponsor
- Institut Cancerologie de l'Ouest
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.